Over the last 12 months the All Ordinaries index has managed to carve out a gain of approximately 6.6%.
Whilst this is a solid gain, it pales in comparison to some of the gains that have been made by constituents of the index.
Three shares that have smashed the market by more than tripling over the last 12 months are listed below. Here's why they have gone gangbusters:
The AVITA Medical Ltd (ASX: AVH) share price has been the biggest mover on the All Ordinaries over the last 12 months with a stunning 512% gain. AVITA Medical is a global regenerative medicine company that provides a novel approach to skin regeneration. Investors have been fighting to get hold of the company's shares due to the potential of its RECELL System, which is a regeneration platform that was approved by the U.S. FDA late last year as a Class III device for the treatment of acute thermal burns. Investors appear to believe the company is well-positioned to generate significant revenue in a U.S. market that management estimates to be worth US$5.7 billion per year at present.
The Jumbo Interactive Ltd (ASX: JIN) share price has risen a massive 274% since this time last year. One of the main catalysts for this gain was the lottery ticket seller's half year results. In the first half of FY 2019 Jumbo recorded a 140% increase in net profit after tax from continuing operations to $12.7 million. In light of this stronger than expected half, management lifted its full year guidance for net profit after tax to $24.2 million. This will be a year on year increase of 107%. The good news for shareholders is that one leading broker thinks its shares can climb higher from here. Morgan Stanley is bullish on the company's prospects and particularly its software-as-a-service business. It has an overweight rating and $20.00 price target on its shares.
The Nearmap Ltd (ASX: NEA) share price has zoomed an impressive 237% over the last 12 months. Investors have been buying the aerial imagery company's shares thanks to its stronger than expected half year result in February. In the first half of FY 2019 Nearmap posted revenue of $36.3 million, up a sizeable 46% on the prior corresponding period. This strong half was driven by growing demand for its services in both the Australian and U.S. markets. The company finished the period with annualised contract value of $78.3 million and a total subscriber lifetime value of $1.07 billion. This was a 44% increase and 123% increase, respectively, on the prior corresponding period.
